Switch to Dark

Pricing

Learn

ABT - Abbott Laboratories

261

$107.19

-$1.30 (-1.198%)

At market close

$107.01

-$0.18 (-0.167%)

Pre Market 3/20/26, 8:01 AM

Score

3.79/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Abbott Laboratories

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	14.35%	10.63%	$11.08B	$11.26B	$10.36B 2025-03-31	$11.46B 2025-12-31	$11.46B 2025-12-31

Operating Expenses	1.34%	1.01%	$4.19B	$4.20B	$4.15B 2025-09-30	$4.22B 2025-06-30	$4.22B 2025-12-31

Net Interest Income Expense	--	35.71%	-$33.75M	-$33.00M	-$42.00M 2025-03-31	-$27.00M 2025-09-30	-$27.00M 2025-12-31

Income Tax Expense	39.46%	28.48%	$485.50M	$494.50M	$371.00M 2025-06-30	$582.00M 2025-12-31	$582.00M 2025-12-31

Cost of Goods Sold (COGS)	13.87%	10.28%	$4.80B	$4.86B	$4.46B 2025-03-31	$5.04B 2025-09-30	$4.91B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue	11,459,000	11,369,000	11,142,000	10,358,000	42,069,000	2881598	8023720	6979779	3979834	3689071	9607885	5711515	8302782	3847092	9847595	9810244	2126949	5706742
Cost of Goods Sold (COGS)	4,913,000	5,037,000	4,798,000	4,455,000	42,069,000	7120185	4108974	8163220	6927072	6323151	3659685	5161849	8665920	7558751	4270531	6755225	7058562	2642589
Gross Profit	6,546,000	6,332,000	6,344,000	5,903,000	42,069,000	2170015	9573973	1673238	3334588	3184976	9916452	6051718	4614545	4921777	6468481	1107570	1698006	2545024
Operating Expenses	4,218,000	4,154,000	4,222,000	4,176,000	42,069,000	5465171	3086126	3347651	3899323	7934367	4415045	6002781	1549528	7453554	1605949	6394799	5117410	1294103
Research & Development	720,000	730,000	718,000	703,000	42,069,000	6904534	4099844	8142363	8696260	8019122	6315047	5968788	6300721	3037056	4410284	487559	1198837	4014695
Selling, General & Administrative Expenses	3,076,000	3,004,000	3,084,000	3,053,000	42,069,000	1623157	8095296	464380	3568916	8075939	9423280	8459753	2722794	1981034	2867767	4202109	8210471	3531530
Operating Income or Loss	2,328,000	2,178,000	2,122,000	1,727,000	42,069,000	7870166	4257265	3903532	221438	2350904	1846564	7431103	1432739	8946643	8794364	1604743	536809	1246632
Interest Expense	-120,000	-121,000	-121,000	-131,000	42,069,000	8598577	7389270	4589128	8050471	6454660	9602845	2482778	4777028	8658144	4538350	6398033	4260226	2134468
Net Interest Income Expense	-27,000	-27,000	-39,000	-42,000	42,069,000	6727949	4231700	942618	7268039	7283371	7391121	1228060	8662328	6483107	9609976	5068135	7420791	4807830
Non-Recurring Items	-242,000	-116,000	-70,000	-34,000	42,069,000	5222171	6359514	6752862	5409116	6607527	3108055	4095633	874896	7120967	--	--	224788	9910661
Total Other Income/Expense Net	299,000	145,000	137,000	127,000	42,069,000	4076118	580568	9232204	9695031	1529026	8899954	2606233	9266257	2713566	5131780	747076	7939859	6251553
Income Before Tax	2,358,000	2,180,000	2,150,000	1,778,000	42,069,000	9508314	3456001	2007318	1772188	8767682	1475161	5561689	4635842	2712243	2202765	9577471	3472196	9463181
Income Tax Expense	582,000	536,000	371,000	453,000	42,069,000	8085409	176217	3993506	7132051	3155078	4633649	5233157	2964235	4749029	952606	6320846	3582909	5994110
Earnings	1,776,000	1,644,000	1,779,000	1,325,000	42,069,000	1292510	7703189	5810469	8796722	7851815	8718177	438433	6061702	1499202	5234404	4834094	5650886	9818714
Adjusted Net Income	1,534,000	1,528,000	1,709,000	1,291,000	42,069,000	3695744	1315978	6718603	6694017	1266073	326184	7462187	7395894	525637	--	--	8296539	3746744
Net Income After Taxes	1,776,000	1,644,000	1,779,000	1,325,000	42,069,000	7040221	6624751	2585452	6744184	3198435	1138597	5055105	4149609	5602312	3091454	8210780	7452683	959847
Diluted Shares Outstanding	1,744,517	1,749,000	1,750,835	1,747,220	42,069	4140862	3452387	188200	2431939	7700591	6395981	2302585	4748580	4376926	7167253	3970009	1960850	734044
Diluted EPS	1.02	0.94	1.02	0.76	42,069	4681884	5992512	3273028	884828	3240130	8850437	156835	2360009	1637112	3950750	4536459	7488697	5474079
Adjusted EPS	0.88	0.87	0.98	0.74	42,069	3102090	9700580	3201950	9944360	5645887	2835788	1068559	4004185	9478427	--	--	8416809	2080948
EBITDA	3,120,000	2,969,000	2,899,000	2,483,000	42,069,000	7788055	8469326	2659766	9855104	5954629	6437893	7223283	8483800	4812616	8244788	5521238	8153266	6192461